Recent Advances in Chemistry and Bioactivities of Secondary Metabolites from the Genus Acremonium

Yuning Qin,Humu Lu,Xin Qi,Miaoping Lin,Chenghai Gao,Yonghong Liu,Xiaowei Luo
DOI: https://doi.org/10.3390/jof10010037
2024-01-03
Journal of Fungi
Abstract:Acremonium fungi is one of the greatest and most complex genera in Hyphomycetes, comprising 130 species of marine and terrestrial sources. The past decades have witnessed substantial chemical and biological investigations on the diverse secondary metabolites from the Acremonium species. To date, over 600 compounds with abundant chemical types as well as a wide range of bioactivities have been obtained from this genus, attracting considerable attention from chemists and pharmacologists. This review mainly summarizes the sources, chemical structures, and biological activities of 115 recently reported new compounds from the genus Acremonium from December 2016 to September 2023. They are structurally classified into terpenoids (42%), peptides (29%), polyketides (20%), and others (9%), among which marine sources are predominant (68%). Notably, these compounds were primarily screened with cytotoxic, antibacterial, and anti-inflammatory activities. This paper provides insights into the exploration and utilization of bioactive compounds in this genus, both within the scientific field and pharmaceutical industry.
microbiology,mycology
What problem does this paper attempt to address?
The paper mainly addresses the following issues: 1. **Summary and Classification**: This review article summarizes the sources, chemical structures, and biological activities of 115 new compounds isolated from the subordinate fungus *Acremonium* from December 2016 to September 2023. These compounds are classified by structure into terpenoids (42%), peptides (29%), polyketides (20%), and other types (9%). 2. **Marine Sources**: Most of these new compounds (68%) come from marine sources, such as sediments (22%), corals (16%), and sponges (12%). 3. **Biological Activity Screening**: These compounds were mainly screened for cytotoxicity, antibacterial, and anti-inflammatory activities. Specifically, this includes: - Antitumor Activity: Such as anti-cancer cell migration and invasion (e.g., marinobazzanan). - Antibacterial Activity: Such as inhibition of various bacteria (e.g., acremopeptaibols and emerimicins). - Anti-inflammatory Activity: Such as inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO) production (e.g., acremeremophilanes and acrepeptins). - Other Biological Activities: Such as enzyme inhibition (e.g., acrepseudoterin) and antioxidant (e.g., orsaldechlorins) activities. 4. **Research Background**: *Acremonium* fungi are a complex and diverse genus, comprising about 130 species. Over the past few decades, more than 600 secondary metabolites with extensive biological activities have been isolated from *Acremonium* fungi, attracting significant attention from chemists and pharmacologists. Through this review, the authors provide important insights into the exploration and utilization of bioactive compounds from *Acremonium* fungi, offering references for scientific research and the pharmaceutical industry.